INmune Bio, Inc. (INMB)
1.46
-0.08
(-5.19%)
USD |
NASDAQ |
Oct 23, 16:00
1.49
+0.03
(+2.05%)
After-Hours: 20:00
INmune Bio Price : 1.46 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 1.53 | 1.53 | 1.45 | 1.46 | 190564.0 |
| Oct 22, 2026 | 1.58 | 1.63 | 1.52 | 1.54 | 220704.0 |
| Oct 21, 2026 | 1.61 | 1.69 | 1.60 | 1.61 | 229971.0 |
| Oct 20, 2026 | 1.53 | 1.63 | 1.53 | 1.60 | 75600.00 |
| Oct 19, 2026 | 1.58 | 1.58 | 1.510 | 1.54 | 156577.0 |
| Oct 16, 2026 | 1.68 | 1.68 | 1.56 | 1.57 | 196169.0 |
| Oct 15, 2026 | 1.60 | 1.68 | 1.53 | 1.65 | 628019.0 |
| Oct 14, 2026 | 1.70 | 1.915 | 1.59 | 1.60 | 1.137M |
| Oct 13, 2026 | 1.77 | 1.79 | 1.64 | 1.68 | 247264.0 |
| Oct 12, 2026 | 1.89 | 1.89 | 1.78 | 1.78 | 72743.00 |
| Oct 09, 2026 | 1.84 | 1.91 | 1.84 | 1.89 | 91631.00 |
| Oct 08, 2026 | 1.85 | 1.87 | 1.79 | 1.83 | 379165.0 |
| Oct 07, 2026 | 1.82 | 1.88 | 1.82 | 1.86 | 104378.0 |
| Oct 06, 2026 | 1.95 | 1.978 | 1.82 | 1.87 | 311074.0 |
| Oct 05, 2026 | 1.90 | 1.97 | 1.88 | 1.94 | 267250.0 |
| Oct 02, 2026 | 1.97 | 1.999 | 1.93 | 1.93 | 290238.0 |
| Oct 01, 2026 | 1.96 | 1.97 | 1.88 | 1.93 | 340814.0 |
| Sep 30, 2026 | 1.98 | 2.02 | 1.94 | 1.95 | 201903.0 |
| Sep 29, 2026 | 2.01 | 2.02 | 1.94 | 1.96 | 286553.0 |
| Sep 28, 2026 | 2.02 | 2.045 | 1.94 | 2.00 | 191597.0 |
| Sep 25, 2026 | 2.01 | 2.04 | 1.96 | 2.03 | 196171.0 |
| Sep 24, 2026 | 2.00 | 2.01 | 1.94 | 2.00 | 167874.0 |
| Sep 23, 2026 | 2.15 | 2.175 | 1.99 | 2.00 | 487604.0 |
| Sep 22, 2026 | 2.31 | 2.36 | 2.16 | 2.16 | 375456.0 |
| Sep 21, 2026 | 2.35 | 2.420 | 2.29 | 2.29 | 306668.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 58.02 |
| Oncolytics Biotech, Inc. | 0.5023 |
| Sangamo Therapeutics, Inc. | 0.115 |
| Sarepta Therapeutics, Inc. | 17.73 |
| Anixa Biosciences, Inc. | 2.99 |
Price Related Metrics
| Price to Book Value | 1.907 |
| Earnings Yield | -47.42% |
| Market Cap | 40.37M |